CLINICAL TRIALS PROFILE FOR INTEPIRDINE
✉ Email this page to a colleague
Clinical Trials for Intepirdine
Trial ID | Title | Status | Sponsor | Phase | Summary |
---|---|---|---|---|---|
NCT02585934 ↗ | Study Evaluating Intepirdine (RVT-101) in Subjects With Mild to Moderate Alzheimer's Disease on Donepezil: MINDSET Study | Completed | Axovant Sciences Ltd. | Phase 3 | This study seeks to confirm a demonstrated treatment effect of intepirdine (RVT-101) as an adjunctive therapy to donepezil for the treatment of subjects with Alzheimer's disease. |
NCT02586909 ↗ | 12-Month Open-Label Extension Study of Intepirdine (RVT-101) in Subjects With Alzheimer's Disease: MINDSET Extension | Terminated | Axovant Sciences Ltd. | Phase 3 | This 12-month open-label study will provide further information regarding the long-term safety and tolerability of intepirdine (RVT-101) for subjects with Alzheimer's disease who have completed the double-blind, placebo-controlled, lead-in study RVT-101-3001 (double-blind study). |
NCT02669433 ↗ | Study Evaluating Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: The HEADWAY-DLB Study | Completed | Axovant Sciences Ltd. | Phase 2 | This study seeks to evaluate the efficacy and safety of intepirdine (RVT-101) in patients with dementia with Lewy bodies. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Summary |
Clinical Trial Conditions for Intepirdine
Condition Name
Clinical Trial Locations for Intepirdine
Trials by Country
Clinical Trial Progress for Intepirdine
Clinical Trial Phase
Clinical Trial Sponsors for Intepirdine
Sponsor Name